Cardinal Health, Inc. (NYSE:CAH) Receives $139.36 Consensus Target Price from Brokerages

Cardinal Health, Inc. (NYSE:CAH) has been given an average rating of “Moderate Buy” by the fourteen research firms that are presently covering the company, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $139.36.

CAH has been the topic of a number of research reports. Citigroup lifted their target price on shares of Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a research note on Friday, January 10th. Bank of America upgraded shares of Cardinal Health from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $132.00 to $145.00 in a report on Monday, January 6th. JPMorgan Chase & Co. upped their price objective on shares of Cardinal Health from $142.00 to $145.00 and gave the stock a “neutral” rating in a report on Tuesday, February 4th. Mizuho assumed coverage on shares of Cardinal Health in a report on Wednesday, December 4th. They issued an “outperform” rating and a $139.00 price objective on the stock. Finally, TD Cowen upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating and upped their price objective for the stock from $130.00 to $144.00 in a report on Wednesday, January 8th.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CAH. Norges Bank bought a new position in Cardinal Health during the fourth quarter valued at approximately $246,748,000. Marshall Wace LLP increased its holdings in Cardinal Health by 154.6% during the fourth quarter. Marshall Wace LLP now owns 3,151,736 shares of the company’s stock valued at $372,756,000 after buying an additional 1,913,892 shares during the last quarter. Castlekeep Investment Advisors LLC purchased a new stake in Cardinal Health during the fourth quarter valued at approximately $141,963,000. Junto Capital Management LP purchased a new stake in Cardinal Health during the fourth quarter valued at approximately $92,811,000. Finally, Woodline Partners LP purchased a new stake in Cardinal Health during the fourth quarter valued at approximately $87,144,000. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Trading Up 1.5 %

Shares of CAH opened at $129.86 on Thursday. The firm’s 50-day moving average price is $126.54 and its 200-day moving average price is $119.56. The firm has a market capitalization of $31.37 billion, a price-to-earnings ratio of 24.23, a PEG ratio of 1.49 and a beta of 0.66. Cardinal Health has a 1-year low of $93.17 and a 1-year high of $132.84.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. On average, research analysts forecast that Cardinal Health will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 dividend on an annualized basis and a yield of 1.56%. Cardinal Health’s dividend payout ratio (DPR) is 37.69%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.